Early response assessment for patients with pancreatic cancer receiving chemotherapy is limited. Detection of alterations in 31P metabolite levels during treatment could change this perspective. However, to date 31P MRS has not yet been demonstrated in the human pancreas in vivo. Here we show in-vivo 31P MRSI data in the pancreas of healthy subjects, using a 31P whole-body transmit coil in combination with a 16-channel receive array at 7T, and show moderate to good test-retest reliability. In addition, we demonstrate the feasibility of performing 31P MRSI in a patient with pancreatic cancer before and after chemotherapy.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords